Abeomics is a company that provides a drug screening platform. It aims to develop well-validated and specific antibodies by traditional hybridoma technology and by genetic engineering to produce recombinant mouse and rabbit monoclonal antibodies. The company offers custom and contract laboratory services, R&D support, screening services, assay development, as well as small- to large-scale manufacturing.